Clinical trial Recruiting at 2 sites Observational Ages 18 and up

Examining the link between kidney function and biomarkers in pulmonary hypertension

Official title: Association Between Biomarkers and Kidney Function Decline in Patients With Pulmonary Hypertension

Run by University of Giessen · NCT06409624 · Data updated 2026-11-12

This study is trying to see how kidney function and certain markers in urine and blood are related in adults with pulmonary hypertension to improve understanding and care for kidney issues in these patients.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorUniversity of Giessen
Academic / other
Locations2 sites (Bad Nauheim, Hesse and 1 other locations)
StatusRecruiting
StartedMay 31, 2024
Main results expectedOctober 2027
Study endsDecember 2027
Registry record updatedSeptember 8, 2026
Trial IDNCT06409624 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are inpatients aged 18 and older with pulmonary hypertension undergoing right heart catheterization.

Probably not a fit

Patients with severe chronic kidney disease (eGFR <20 ml/min/1.73 m2) or those with active tumor disease or other significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the relationship between urinary and plasma biomarkers and changes in estimated glomerular filtration rate (eGFR) in patients with pulmonary hypertension (PH). Given that kidney disease is prevalent in approximately 35% of PH patients and is associated with worse outcomes, understanding the mechanisms connecting heart and kidney function is crucial. The study will involve inpatients aged 18 and older who are undergoing right heart catheterization, without any planned interventions. By identifying potential biomarkers, the research seeks to enhance diagnostic and prognostic capabilities for kidney disease in the context of PH.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic tools and treatment strategies for patients with pulmonary hypertension and concurrent kidney disease.

How similar studies have gone: While the specific approach of linking biomarkers to kidney function in PH is novel, similar studies have shown the importance of biomarkers in understanding disease progression in related conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Inpatients aged ≥18 years
* Undergoing right heart catheterization (RHC)

Exclusion Criteria:

* multifactorial or indeterminate PH, for which no single underlying mechanism could be reliably classified
* active tumor disease requiring targeted therapy
* inflammatory or autoimmune disease with renal involvement requiring systemic immunosuppressive treatment
* unexplained kidney function decline, defined as serum creatinine increase ≥0.5 mg/dL from baseline within the prior 7 days before RHC
* Chronic kidney disease with eGFR \<20 ml/min/1.73 m2
* non-kidney failure requiring extracorporeal or peritoneal ultrafiltration for diuretic-resistant volume overload
* if they had received non-steroidal anti-inflammatory drugs or intravenous contrast within 72 hours before RHC
* prediagnosed glomerulonephritis
* polycystic kidney disease
* postrenal obstruction
* single kidney (functional or anatomical)
* solid organ transplantation
* anticipated life expectancy of \<12 months
* likelihood of receiving advanced therapy (mechanical circulatory assist device/lung or cardiac transplant)
* pregnancy or possibility of pregnancy in the next 12 months
* inability to cooperate with respiratory maneuvers during renal Doppler
* refusal to participate
* not available for follow-up visits

Where it's running

  • Kerckhoff Klinik Heart and Thorax Center
    Bad Nauheim, Hesse, Germany
    Recruiting
  • University Hospital Giessen and Marburg, Campus Giessen, Department of Internal Medicine II
    Giessen, Hesse, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.